09:59 AM EST - MediPharm Labs Corp. : Announced that the Company’s research partner McMaster University has received a no objection letter from Health Canada to proceed with research with MediPharm Labs CBD50 and CBD10:2. This is a key milestone in moving forward with the Company’s strategy to be the go-to cannabis partner for pharmaceuticals containing cannabis. MediPharm Labs Corp.
shares T.LABS are trading unchanged at $0.33.
